More recently, tranilast increased NLRP3 ubiquitination in two murine models of atherosclerosis, which inhibited the assembly of the NLRP3 inflammasome and, as a result, slowed the development and spread of atherosclerotic plaques (192). Here, NLRP3 is linked to atherosclerosis.